Cargando…

Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients

We analyzed cytokine responses against latent and lytic Epstein-Barr virus (EBV) antigens in systemic lupus erythematosus (SLE) patients and healthy controls (HCs) to obtain an overview of the distinctive immune regulatory response in SLE patients and to expand the previously determined impaired EBV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Draborg, Anette Holck, Sandhu, Noreen, Larsen, Nanna, Lisander Larsen, Janni, Jacobsen, Søren, Houen, Gunnar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826706/ https://www.ncbi.nlm.nih.gov/pubmed/27110576 http://dx.doi.org/10.1155/2016/6473204

Ejemplares similares

Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patients
por: Draborg, Anette Holck, et al.
Publicado: (2014)

Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status
por: Draborg, Anette Holck, et al.
Publicado: (2018)

Epstein-Barr Virus and Systemic Lupus Erythematosus
por: Draborg, Anette Holck, et al.
Publicado: (2012)

EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls
por: Trier, Nicole Hartwig, et al.
Publicado: (2019)

Epstein-Barr Virus in Systemic Autoimmune Diseases
por: Draborg, Anette Holck, et al.
Publicado: (2013)

Elevated Antibody Titers to Epstein–Barr Virus and Cytomegalovirus in Patients with Drug-Induced Lupus
por: Knudsen, Julie, et al.
Publicado: (2023)

Isotypes of Epstein-Barr Virus Antibodies in Rheumatoid Arthritis: Association with Rheumatoid Factors and Citrulline-Dependent Antibodies
por: Westergaard, Marie Wulff, et al.
Publicado: (2015)

Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies
por: Draborg, Anette H., et al.
Publicado: (2015)

Correction: Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies
por: Draborg, Anette H., et al.
Publicado: (2016)

Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients
por: Rasmussen, NS, et al.
Publicado: (2015)

Altered Antibody Response to Epstein-Barr Virus in Patients With Rheumatoid Arthritis and Healthy Subjects Predisposed to the Disease. A Twin Study
por: Svendsen, Anders J., et al.
Publicado: (2021)

Epstein-Barr Virus and Systemic Autoimmune Diseases
por: Houen, Gunnar, et al.
Publicado: (2021)

Epstein-Barr Virus and Multiple Sclerosis
por: Houen, Gunnar, et al.
Publicado: (2020)

Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus
por: Jog, Neelakshi R., et al.
Publicado: (2021)

Reactivity of Rheumatoid Arthritis-Associated Citrulline-Dependent Antibodies to Epstein-Barr Virus Nuclear Antigen1-3
por: Fanelli, Ilaria, et al.
Publicado: (2022)

Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis
por: Trier, Nicole Hartwig, et al.
Publicado: (2018)

Exhausted Cytotoxic Control of Epstein-Barr Virus in Human Lupus
por: Larsen, Martin, et al.
Publicado: (2011)

Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus
por: Chen, Xiaotong, et al.
Publicado: (2023)

Patients with systemic lupus erythematosus have abnormally elevated Epstein–Barr virus load in blood
por: Moon, Uk Yeol, et al.
Publicado: (2004)

Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation
por: Lossius, Andreas, et al.
Publicado: (2012)

Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at risk individuals
por: Jog, Neelakshi R., et al.
Publicado: (2019)

Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions
por: Buonavoglia, Alessio, et al.
Publicado: (2021)

Age-related Epstein-Barr Virus-associated Lymphoproliferative Disorder Masquerading as Systemic Lupus Erythematosus
por: Kadoba, Keiichiro, et al.
Publicado: (2021)

Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site
por: Csorba, Kinga, et al.
Publicado: (2019)

The Possible Effect of B-Cell Epitopes of Epstein–Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus
por: Tu, Jianxin, et al.
Publicado: (2018)

Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands—Relation to Rheumatoid Arthritis
por: Trier, Nicole, et al.
Publicado: (2018)

Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus
por: Hanlon, Peter, et al.
Publicado: (2014)

The risk of systemic lupus erythematosus associated with Epstein–Barr virus infection: a systematic review and meta-analysis
por: Li, Zhao-Xia, et al.
Publicado: (2018)

Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity
por: Munroe, Melissa E., et al.
Publicado: (2021)

Qualitative factors shaping MS patients’ experiences of infusible disease-modifying drugs: a critical incident technique analysis
por: Larsen, Janni Lisander, et al.
Publicado: (2020)

Correlation between Epstein-Barr Virus Infection and Disease Activity of Systemic Lupus Erythematosus: a Cross-Sectional Study
por: Piroozmand, Ahmad, et al.
Publicado: (2017)

Cytokines in Systemic Lupus Erythematosus
por: Poole, Brian D., et al.
Publicado: (2010)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Lymphocytic Interstitial Pneumonitis Associated with Epstein-Barr virus in Systemic Lupus Erythematosus and Sjögren’s Syndrome.: Complete remission with corticosteroid and cyclophosphamide
por: Yum, Ho-Kee, et al.
Publicado: (2002)

Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial　tissues of rheumatoid arthritis
por: Masuoka, Shotaro, et al.
Publicado: (2018)

Are Selected Cytokines and Epstein–Barr Virus DNA Load Predictors of Hepatological Complications of Epstein–Barr Virus Infection in Children?
por: Moppert, Justyna, et al.
Publicado: (2023)

Epstein–Barr Virus Reactivation as a New Predictor of Achieving Remission or Lupus Low Disease Activity State in Patients with Systemic Lupus Erythematosus with Cutaneous Involvement
por: Miskovic, Rada, et al.
Publicado: (2023)

Cytokine Networks in Systemic Lupus Erythematosus
por: Lee, Hooi-Ming, et al.
Publicado: (2010)

Cytokines in Systemic Lupus Erythematosus 2011
por: Poole, Brian D., et al.
Publicado: (2012)

Inflammatory Cytokines in Systemic Lupus Erythematosus
por: Ohl, Kim, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_n1llktu5d2c6bjlkfvkh63ckq6